Benutzer: Gast  Login
Mehr Felder
Einfache Suche
Dokumenttyp:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Autor(en):
Curran, D; Pozzo, C; Zaluski, J; Dank, M; Barone, C; Valvere, V; Yalcin, S; Peschel, C; Wenczl, M; Goker, E; Bugat, R
Titel:
Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial.
Abstract:
PURPOSE: The quality of life (QL) of advanced gastric cancer patients receiving irinotecan, folinic acid and 5-fluorouracil (5-FU) (IF arm) or cisplatin with 5-FU (CF arm) is presented. METHODS: Patients with measurable or evaluable advanced gastric cancer received IF weekly for 6/7 weeks or CF q4 weeks. QL was assessed using the EORTC QLQ-C30 at baseline, subsequently every 8 weeks until progression and thereafter every 3 months until death. The QL data were analysed using several statistical m...     »
Zeitschriftentitel:
Qual. Life Res.
Jahr:
2009
Band / Volume:
18
Heft / Issue:
7
Seitenangaben Beitrag:
853-61
Sprache:
eng
Volltext / DOI:
doi:10.1007/s11136-009-9493-z
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/19568958
Print-ISSN:
0962-9343
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX